161 related articles for article (PubMed ID: 10570426)
1. Second primary tumors in patients with cutaneous malignant melanoma.
Bhatia S; Estrada-Batres L; Maryon T; Bogue M; Chu D
Cancer; 1999 Nov; 86(10):2014-20. PubMed ID: 10570426
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
Schenk M; Severson RK; Pawlish KS
Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
[TBL] [Abstract][Full Text] [Related]
4. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
5. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
6. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
7. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
8. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
10. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
Frisch M; Hjalgrim H; Olsen JH; Melbye M
Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988
[TBL] [Abstract][Full Text] [Related]
11. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
12. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
Crocetti E; Carli P
Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
17. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
18. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive cancers following squamous cell skin cancer.
Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary cancer in men with breast cancer.
Satram-Hoang S; Ziogas A; Anton-Culver H
Breast Cancer Res; 2007; 9(1):R10. PubMed ID: 17254323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
